Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview.

Abstract

Acute leukaemia of ambiguous lineage (ALAL) is a rare complex entity with heterogeneous clinical, immunophenotypic, cytogenetic and molecular genetic features and adverse outcome. According to World Health Organization 2008 classification, ALAL encompasses those leukaemias that show no clear evidence of differentiation along a single lineage. The rarity of ALAL and the lack of uniform diagnostic criteria have made it difficult to establish its cytogenetic features, although cytogenetic analysis reveals clonal chromosomal abnormalities in 59-91% of patients. This article focuses on the significance of cytogenetic analysis in ALAL supporting the importance of cytogenetic analysis in the pathogenesis, diagnosis, prognosis, follow up and treatment selection of ALAL. It reviews in detail the types of chromosomal aberrations, their molecular background, their correlation with immunophenotype and age distribution and their prognostic relevance. It also summarizes some novel chromosome aberrations that have been observed only once. Furthermore, it highlights the ongoing and future research on ALAL in the field of cytogenetics.

• Authors: Kalliopi N Manola
• Journal: British journal of haematology (Br J Haematol) Vol. 163 Issue 1 Pg. 24-39 (Oct 2013) ISSN: 1365-2141 [Electronic] England
• PMID: 23888868 (Publication Type: Journal Article, Review)
• Copyright: © 2013 John Wiley & Sons Ltd.

Topics

• Age Factors
• Chromosome Aberrations
• Cytogenetics
• Humans
• Immunophenotyping
• Leukemia, Biphenotypic, Acute (diagnosis, genetics, therapy)
• Prognosis
• Research
• Treatment Outcome